These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7512295)

  • 1. Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia.
    Björk T; Bjartell A; Abrahamsson PA; Hulkko S; di Sant'Agnese A; Lilja H
    Urology; 1994 Apr; 43(4):427-34. PubMed ID: 7512295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epithelium.
    Bjartell A; Björk T; Matikainen MT; Abrahamsson PA; di Sant'Agnese A; Lilja H
    Urology; 1993 Nov; 42(5):502-10. PubMed ID: 7694414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia.
    Ansong K
    Urology; 1994 Aug; 44(2):296-7. PubMed ID: 7519383
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of serum prostate-specific antigen-alpha1-antichymotrypsin complex values in diagnosis of prostate cancer: a cooperative study.
    Kuriyama M; Ueno K; Uno H; Kawada Y; Akimoto S; Noda M; Nasu Y; Tsushima T; Ohmori H; Sakai H; Saito Y; Meguro N; Usami M; Kotake T; Suzuki Y; Arai Y; Shimazaki J
    Int J Urol; 1998 Jan; 5(1):48-54. PubMed ID: 9535601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implications.
    Jung K; Brux B; Lein M; Rudolph B; Kristiansen G; Hauptmann S; Schnorr D; Loening SA; Sinha P
    Clin Chem; 2000 Jan; 46(1):47-54. PubMed ID: 10620571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific antigen and its complexes with alpha 1-antichymotrypsin in the plasma of patients with prostatic disease.
    España F; Martínez M; Sánchez-Cuenca J; Vera CD; Estellés A; Jiménez-Cruz JF
    Eur Urol; 1996; 30(4):512-8. PubMed ID: 8977078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proportion of prostate-specific antigen (PSA) complexed to alpha(1)-antichymotrypsin improves the discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA of 10 to 30 microg/L.
    Martínez M; España F; Royo M; Alapont JM; Navarro S; Estellés A; Aznar J; Vera CD; Jiménez-Cruz JF
    Clin Chem; 2002 Aug; 48(8):1251-6. PubMed ID: 12142381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical finding of alpha-1-antichymotrypsin in tissues of benign prostatic hyperplasia and prostate cancer.
    Tanaka M; Suzuki Y; Takaoka K; Murakami S; Suzuki N; Shimazaki J
    Int J Urol; 1999 Dec; 6(12):600-6. PubMed ID: 10609542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of alpha-1-antichymotrypsin in prostate carcinoma.
    Cho NH; Park C; Park DS
    J Korean Med Sci; 1997 Jun; 12(3):228-33. PubMed ID: 9250919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia.
    Mikolajczyk SD; Millar LS; Wang TJ; Rittenhouse HG; Wolfert RL; Marks LS; Song W; Wheeler TM; Slawin KM
    Urology; 2000 Jan; 55(1):41-5. PubMed ID: 10654892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the enzymatic activity of prostate-specific antigen and its reactions with extracellular protease inhibitors in prostate cancer.
    Lilja H
    Scand J Clin Lab Invest Suppl; 1995; 220():47-56. PubMed ID: 7544478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSA forms complexes with α1-antichymotrypsin in prostate.
    Zhu L; Jäämaa S; Af Hällström TM; Laiho M; Sankila A; Nordling S; Stenman UH; Koistinen H
    Prostate; 2013 Jan; 73(2):219-26. PubMed ID: 22806587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evaluation of proliferating cell nuclear antigen, prostate-specific antigen and alpha 1-antichymotrypsin in human prostate cancer.
    Igawa M; Urakami S; Shiina H; Ishibe T; Shirane T; Usui T; Chodak GW
    Br J Urol; 1996 Jan; 77(1):107-12. PubMed ID: 8653279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.
    Lein M; Jung K; Elgeti U; Brux B; Sinha P; Schnorr D; Loening SA
    Anticancer Res; 2000; 20(6D):4997-5001. PubMed ID: 11326657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex.
    Wan XS; Xu YA; Ware JH; Kennedy AR
    Prostate; 2003 Jul; 56(2):131-41. PubMed ID: 12746838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA.
    Jung K; Brux B; Lein M; Knäbich A; Sinha P; Rudolph B; Schnorr D; Loening SA
    Urology; 1999 Jun; 53(6):1160-7; discussion 1167-8. PubMed ID: 10367846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer.
    Christensson A; Björk T; Nilsson O; Dahlén U; Matikainen MT; Cockett AT; Abrahamsson PA; Lilja H
    J Urol; 1993 Jul; 150(1):100-5. PubMed ID: 7685416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen complexed to alpha-1-antichymotrypsin in patients with intermediate prostate specific antigen levels.
    Saika T; Tsushima T; Nasu Y; Kusaka N; Miyaji Y; Takamoto H; Takeda K; Uno S; Kumon H;
    Cancer; 2002 Mar; 94(6):1685-91. PubMed ID: 11920529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis.
    Lein M; Jung K; Elgeti U; Petras T; Stephan C; Brux B; Sinha P; Winkelmann B; Schnorr D; Loening S
    Eur Urol; 2001 Jan; 39(1):57-64. PubMed ID: 11173940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.